Hepatitis B diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:


[[File:HepB Assay Results.jpg|thumb|center|700px|Hepatitis B assay results <SMALL> Adapted from ''[http://www.who.int/en/ World Health Organization]''<ref>{{Cite web | title = http://www.who.int/en/ | url = http://www.who.int/en/}}</ref></SMALL>]]
[[File:HepB Assay Results.jpg|thumb|center|700px|Hepatitis B assay results <SMALL> Adapted from ''[http://www.who.int/en/ World Health Organization]''<ref>{{Cite web | title = http://www.who.int/en/ | url = http://www.who.int/en/}}</ref></SMALL>]]
===Antigens===
====HBsAg====
Hepatitis B surface antigen is the earliest indicator of acute infection and is also indicative of chronic [[infection]] if its presence persists for more than 6 months. It is useful for the diagnosis of [[HBV]] infection and for [[screening]] of blood. Its specific [[antibody]] is anti-HBs. [[HBsAg]] indicates that the person is potentially [[infectious]].
====HBcAg====
Hepatitis B core antigen is derived from the protein envelope that encloses the [[viral]] DNA, and it is not detectable in the [[bloodstream]]. When HBcAg peptides are expressed on the surface of [[hepatocytes]], they induce an [[immune]] response that is crucial for killing infected cells. The HBcAg is a marker of the infectious viral material and it is the most accurate index of [[viral replication]]. Its specific [[antibody]] is anti-HBc.
====HBeAg====
Hepatitis B e antigen appearing during weeks 3 to 6 indicates an acute active infection at its most [[infectious]] period, and means that the patient is [[infectious]]. Persistence of this virological marker beyond 10 weeks shows progression to chronic infection and infectiousness. Continuous presence of anti-HBe indicates chronic or chronic active liver disease. HBeAg is not incorporated into [[virions]], but is instead secreted into the [[serum]]. Mutant strains of HBV exist that replicate without producing HBeAg. HBeAg’s function is uncertain. Its specific [[antibody]] is anti-HBe.
====HBxAg====
Hepatitis B x antigen is detected in HBeAg positive blood in patients with both acute and chronic hepatitis. HBxAg is a transcriptional activator. It does not bind to [[DNA]]. Its specific [[antibody]] is anti-HBx.
====HBV DNA====
HBV DNA is detectable by PCR as soon as 1 week after initial infection, but the test is generally only performed for research purposes or to detect mutants that escape detection by current methods.
====HBV DNA Polymerase====
Tests for the presence of [[HBV]] [[DNA polymerase]], detectable within 1 week of initial infection, are only performed for research purposes.
===Antibodies===
====Anti-HBs====
This is the specific [[antibody]] to hepatitis B surface antigen. Its appearance 1 to 4 months after onset of [[symptoms]] indicates clinical recovery and subsequent immunity to HBV. Anti-HBs can neutralize HBV and provide protection against HBV infection.
====Anti-HBc====
This is the specific [[antibody]] to hepatitis B core antigen. [[Antibodies]] to HBc are of class IgM and IgG. They do not neutralize the [[virus]]. The presence of [[IgM]] identifies an early acute [[infection]]. In the absence of [[HBsAg]] and anti-HBs, it shows recent [[infection]]. IgG with no IgM may be present in chronic and resolved infections. Anti-HBc testing identifies all previously infected persons, including [[HBV]] carriers, but does not differentiate carriers and non-carriers.
====Anti-HBe====
This is the specific [[antibody]] to hepatitis B e antigen. During the acute stage of infection the [[seroconversion]] from e antigen to e antibody is [[prognostic]] for resolution of [[infection]]. Its presence in the patient’s blood along with anti-HBc and in the absence of HBsAg and anti-HBs indicates low contagiousness and convalescence.
====Anti-HBx====
This is the specific [[antibody]] to hepatitis B x antigen. It appears when other [[virus|virological]] markers are becoming undetectable.


==References==
==References==

Revision as of 18:22, 31 July 2014

Hepatitis Main Page

Hepatitis B

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis B from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatitis B diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis B diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis B diagnostic criteria

CDC on Hepatitis B diagnostic criteria

Hepatitis B diagnostic criteria in the news

Blogs on Hepatitis B diagnostic criteria

Directions to Hospitals Treating Hepatitis B

Risk calculators and risk factors for Hepatitis B diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Diagnosis of hepatitis is made by biochemical assessment of liver function. Initial laboratory evaluation should include: total and direct bilirubin, ALT, AST, alkaline phosphatase, prothrombin time, total protein, albumin, globulin, complete blood count, and coagulation studies. Diagnosis is confirmed by demonstration in sera of specific antigens and/or antibodies. Three clinical useful antigen-antibody systems have been identified for hepatitis B, such as: hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs); antibody (anti-HBc IgM and anti-HBc IgG) to hepatitis B core antigen (HBcAg) and hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe).[1]

Diagnostic Criteria

The three standard blood tests for hepatitis B can determine if a person is currently infected with HBV, has recovered, is a chronic carrier, or is susceptible to HBV infection:[1]

Hepatitis B assay results Adapted from World Health Organization[2]

References

  1. 1.0 1.1 "Hepatitis B".
  2. "http://www.who.int/en/". External link in |title= (help)

Template:STD/STI

Template:WH Template:WS